JP5160788B2 - 化合物、その化合物を含む組成物、その化合物を利用した自己免疫疾患の治療方法 - Google Patents

化合物、その化合物を含む組成物、その化合物を利用した自己免疫疾患の治療方法 Download PDF

Info

Publication number
JP5160788B2
JP5160788B2 JP2006540119A JP2006540119A JP5160788B2 JP 5160788 B2 JP5160788 B2 JP 5160788B2 JP 2006540119 A JP2006540119 A JP 2006540119A JP 2006540119 A JP2006540119 A JP 2006540119A JP 5160788 B2 JP5160788 B2 JP 5160788B2
Authority
JP
Japan
Prior art keywords
compound
antibody
tnfα
pharmaceutical composition
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006540119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512259A5 (cg-RX-API-DMAC7.html
JP2007512259A (ja
Inventor
ペニー,クリストファー
ザシャリー,ブーロ
デー. アボット,シャウン
ビヤンブニュ,ジャン−フランソワ
デー. カメロン,アラン
ドゥセップ,ジャン−シモン
エッジトウニ,アブダラー
フォルティン,ダニエル
ウデ,カリーヌ
モロー,ナンシー
ウィルブ,ニコル
グロワ,ブリジット
ガノン,レーン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prometic Biosciences Inc
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of JP2007512259A publication Critical patent/JP2007512259A/ja
Publication of JP2007512259A5 publication Critical patent/JP2007512259A5/ja
Application granted granted Critical
Publication of JP5160788B2 publication Critical patent/JP5160788B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2006540119A 2003-11-24 2004-11-22 化合物、その化合物を含む組成物、その化合物を利用した自己免疫疾患の治療方法 Expired - Fee Related JP5160788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52402103P 2003-11-24 2003-11-24
US60/524,021 2003-11-24
PCT/CA2004/002003 WO2005049607A1 (en) 2003-11-24 2004-11-22 Triazine dimers for the treatment of autoimmune diseases

Publications (3)

Publication Number Publication Date
JP2007512259A JP2007512259A (ja) 2007-05-17
JP2007512259A5 JP2007512259A5 (cg-RX-API-DMAC7.html) 2007-11-08
JP5160788B2 true JP5160788B2 (ja) 2013-03-13

Family

ID=34619624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540119A Expired - Fee Related JP5160788B2 (ja) 2003-11-24 2004-11-22 化合物、その化合物を含む組成物、その化合物を利用した自己免疫疾患の治療方法

Country Status (13)

Country Link
US (1) US7683061B2 (cg-RX-API-DMAC7.html)
EP (1) EP1687297B1 (cg-RX-API-DMAC7.html)
JP (1) JP5160788B2 (cg-RX-API-DMAC7.html)
AU (1) AU2004291186B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416843A8 (cg-RX-API-DMAC7.html)
CA (1) CA2554635C (cg-RX-API-DMAC7.html)
DK (1) DK1687297T3 (cg-RX-API-DMAC7.html)
ES (1) ES2501169T3 (cg-RX-API-DMAC7.html)
IL (1) IL175814A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06005879A (cg-RX-API-DMAC7.html)
PL (1) PL1687297T3 (cg-RX-API-DMAC7.html)
PT (1) PT1687297E (cg-RX-API-DMAC7.html)
WO (1) WO2005049607A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007130077A (ru) * 2005-01-07 2009-02-20 Эмори Юниверсити (Us) Антагонисты cxcr4 и их применение для лечения вич-инфекции
AU2006203826A1 (en) 2005-01-07 2006-07-13 Emory University CXCR4 antagonists for the treatment of HIV infection
JP2008540585A (ja) 2005-05-19 2008-11-20 プロメティック・バイオサイエンスィズ・インコーポレーテッド 転移性メラノーマ及び他の癌を治療するための化合物、そのような化合物を含有する組成物、および治療方法
US8444879B2 (en) * 2006-05-08 2013-05-21 Basf Se Triazine derivatives
US8080659B2 (en) * 2006-07-11 2011-12-20 Emory University CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
US9510982B2 (en) 2010-01-13 2016-12-06 Ferno-Washington, Inc. Powered roll-in cots
BR112012029647A2 (pt) 2010-05-21 2016-08-02 Chemilia Ab novos derivados de pirimidinas
MX2013010898A (es) 2011-03-24 2013-12-06 Chemilia Ab Novedoso derivados de la pirimidina.
GB201119358D0 (en) 2011-11-10 2011-12-21 Lewi Paulus J Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
USD751000S1 (en) 2013-06-17 2016-03-08 Ferno-Washington, Inc. Control panel of a patient transport device having surface ornamentation
JP6530749B2 (ja) 2013-11-15 2019-06-12 ファーノ−ワシントン・インコーポレーテッド 自己作動型簡易ベッド
JP2017509441A (ja) 2014-04-04 2017-04-06 ファーノ−ワシントン・インコーポレーテッド 自動的な連結式簡易ベッドのための方法及びシステム

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2392607A (en) * 1946-01-08 Preparation of mono-aryl melamines
US2544071A (en) * 1951-03-06 Diethylenetrimelamine and method
GB122458A (en) * 1918-01-22 1919-01-22 Regent Carriage Company Ltd Improvements in or relating to Strainers and like Devices for use on Aircraft.
BE707403A (cg-RX-API-DMAC7.html) * 1966-12-03 1968-04-16
JPS4925501B1 (cg-RX-API-DMAC7.html) * 1969-07-21 1974-07-01
IT1060458B (it) * 1975-12-18 1982-08-20 Chimosa Chimica Organica Spa Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
US4269832A (en) * 1978-04-12 1981-05-26 American Cyanamid Company Method of treating arthritic disease
GB2053926B (en) * 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
FR2518106B1 (fr) * 1981-12-11 1986-12-05 Sandoz Sa Procede de teinture et d'impression de substrats organiques a l'aide de colorants directs bisazoiques
JPS58179263A (ja) * 1982-04-13 1983-10-20 Ube Ind Ltd 難燃性ポリアミド組成物
EP0101411B1 (de) * 1982-08-11 1989-01-25 Ciba-Geigy Ag Verfahren zur chemischen Bindung von Stabilisatoren an Polymere
DE3440777C2 (de) * 1983-11-14 1998-09-03 Clariant Finance Bvi Ltd Neue sulfonsäuregruppenhaltige, basische Azoverbindungen, deren Herstellung und Verwendung als Farbstoffe
JPS60260655A (ja) * 1984-06-06 1985-12-23 Mitsubishi Chem Ind Ltd ジスアゾ化合物及びセルロース繊維類用ジスアゾ反応性染料
JPS61225232A (ja) * 1985-03-29 1986-10-07 Adeka Argus Chem Co Ltd ポリオレフイン樹脂組成物
DE3518375C1 (de) * 1985-05-22 1986-07-17 Degussa Ag, 6000 Frankfurt Oxymethylencopolymerisat-Formmassen mit verminderter Formaldehyd-Emission bei der thermoplastischen Verarbeitung
JPS61272270A (ja) * 1985-05-28 1986-12-02 Mitsubishi Chem Ind Ltd ジスアゾ系化合物
JPH0619046B2 (ja) * 1985-12-06 1994-03-16 三菱化成株式会社 ジスアゾ化合物およびそれを含有する染料組成物
JPH07109526B2 (ja) * 1987-03-05 1995-11-22 日本化薬株式会社 電子写真用トナ−
JPH01154140A (ja) * 1987-12-11 1989-06-16 Fuji Photo Film Co Ltd 感光性マイクロカプセル及び感光材料
US4963461A (en) * 1987-10-02 1990-10-16 Fuji Photo Film Co., Ltd. Light-sensitive micropcapsule and light-sensitive material employing the same
GB8801486D0 (en) * 1988-01-22 1988-02-24 Ici Plc Water-soluble dye
DE58907811D1 (de) * 1988-03-16 1994-07-14 Ciba Geigy Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung.
US4972010A (en) * 1988-09-21 1990-11-20 Uniroyal Chemical Company, Inc. Substituted triazines
GB9016449D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
GB9016448D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
US5374301A (en) * 1990-07-26 1994-12-20 Zeneca Limited Inks suitable for use in ink jet printing
JPH04295860A (ja) * 1991-03-25 1992-10-20 Ricoh Co Ltd 画像形成方法
IT1252291B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Composizioni polimeriche autoestinguenti
IT1252292B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Policondensati melamminici
GB9220964D0 (en) * 1991-11-15 1992-11-18 Ici Plc Anionic compounds
CH684948A5 (de) * 1992-05-13 1995-02-15 Sandoz Ag Basische sulfogruppenhaltige Disazoverbindungen.
JP3210095B2 (ja) * 1992-10-13 2001-09-17 ハッコールケミカル株式会社 有機白色顔料
JPH06329933A (ja) * 1993-05-19 1994-11-29 Canon Inc 染料化合物、これを含有するインク、このインクを用いる記録方法、及び、かかるインクを用いた機器
US5631352A (en) * 1994-06-20 1997-05-20 Ciba-Geigy Corporation Azodyes containing a bridge member based on diamino-substituted triazines
JPH0895281A (ja) * 1994-09-29 1996-04-12 Canon Inc 記録紙及びこれを用いた画像形成方法
JPH10291365A (ja) * 1997-04-21 1998-11-04 Fuji Xerox Co Ltd 多色インクセット及びインクジェット記録方法
JPH1148609A (ja) * 1997-08-04 1999-02-23 Fuji Xerox Co Ltd 画像記録方法及び画像記録装置
US6365719B1 (en) * 1997-09-22 2002-04-02 Clariant Finance (Bvi) Limited Bridged disazo compounds
US6482255B1 (en) * 1997-10-24 2002-11-19 Avecia Limited Disazodyes for ink jet printing
GB9820176D0 (en) * 1998-09-16 1998-11-11 Zeneca Ltd Inks
GB9929318D0 (en) * 1999-12-10 2000-02-02 Prometic Biosciences Limited Macrocyclic compounds and their use
US6153365A (en) * 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing compositions containing stain reducing agent
CA2396693A1 (en) * 1999-12-28 2001-07-05 Stephen T. Wrobleski Cytokine, especially tnf-alpha, inhibitors
JP5142432B2 (ja) * 2000-08-08 2013-02-13 キヤノン株式会社 蛍光インク、インクジェット記録方法、記録ユニット、インクカートリッジ、インクジェット記録装置、蛍光増強方法及び蛍光の長寿命化方法
AU2002222646A1 (en) * 2000-12-14 2002-06-24 Fuji Photo Film Co. Ltd. Substantially colorless and optically anisotropic material
JP4139558B2 (ja) * 2000-12-27 2008-08-27 富士フイルム株式会社 ビストリアジニルアリーレンジアミン誘導体とジアミノスチルベン誘導体とを含有する写真処理組成物及び画像形成方法
JP2002275397A (ja) * 2001-03-16 2002-09-25 Canon Inc インクセット、それを用いたインクジェット記録方法、記録ユニット、インクカートリッジ、及びインクジェット記録装置
GB2379706A (en) * 2001-09-18 2003-03-19 Procorp Designs Ltd Sliding sash window assembly

Also Published As

Publication number Publication date
WO2005049607A1 (en) 2005-06-02
ES2501169T3 (es) 2014-10-01
EP1687297B1 (en) 2014-06-18
BRPI0416843A (pt) 2007-02-13
CA2554635C (en) 2013-06-18
PT1687297E (pt) 2014-09-18
AU2004291186A1 (en) 2005-06-02
MXPA06005879A (es) 2007-01-26
US7683061B2 (en) 2010-03-23
PL1687297T3 (pl) 2014-11-28
AU2004291186B2 (en) 2012-01-19
WO2005049607B1 (en) 2005-07-14
US20070149528A1 (en) 2007-06-28
EP1687297A1 (en) 2006-08-09
EP1687297A4 (en) 2009-04-22
IL175814A0 (en) 2006-10-05
JP2007512259A (ja) 2007-05-17
BRPI0416843A8 (pt) 2019-01-02
CA2554635A1 (en) 2005-06-02
DK1687297T3 (da) 2014-09-22

Similar Documents

Publication Publication Date Title
US11945805B2 (en) Inhibitors of CXCR2
CN101679321B (zh) 三嗪衍生物、含所述衍生物的组合物以及所述衍生物在制备用于治疗癌症和自身免疫性疾病药物中的应用
JP6207100B2 (ja) イソキノリノンまたはキナゾリノンホスファチジルイノシトール3−キナーゼ阻害剤
AU2003282726B2 (en) Vasculostatic agents and methods of use thereof
CN101855203B (zh) F1f0-atp合成酶抑制剂以及相关的方法
JP2007512259A (ja) 化合物、その化合物を含む組成物、その化合物を利用した自己免疫疾患の治療方法
CN110177788A (zh) 作为bcl-2选择性凋亡诱导剂的化合物
IL312955B1 (en) Fused piperidinyl bicyclic compounds and related compounds as C5a receptor modulators
KR20160078400A (ko) 글루타르이미드 유도체를 포함하는 약학적 조성물 및 호산구성 질병 치료에 있어서의 그 용도
JP2024502474A (ja) Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
JP2003533515A (ja) TNFαシグナル伝達のモジュレータ
US20090068169A1 (en) 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
SA04250149A (ar) مركبات جديدة
CA2608314C (en) Compounds and their use for the treatment of autoimmune diseases
JP2007518781A (ja) ケモカイン受容体モジュレーターとしてのスルホンアミド置換トリアジン
CN114751874A (zh) 作为TRPV4-KCa2.3促耦联剂的1-苄基-4-乙基哌嗪衍生物及其应用
JP2023180347A (ja) ハイブリッド型化合物又はその塩
EA048753B1 (ru) Пиридинилзамещенные оксоизоиндолиновые соединения

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070831

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101206

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110307

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120426

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121011

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121213

R150 Certificate of patent or registration of utility model

Ref document number: 5160788

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151221

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S303 Written request for registration of pledge or change of pledge

Free format text: JAPANESE INTERMEDIATE CODE: R316303

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees